title: Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab.
authors.forename: Francisca
authors.initials: F
authors.lastname: Llinares-Tello
authors.forename: José Rosas Gómez
authors.initials: JR
authors.lastname: de Salazar
authors.forename: José Miguel Senabre
authors.initials: JM
authors.lastname: Gallego
authors.forename: Gregorio Santos
authors.initials: GS
authors.lastname: Soler
authors.forename: Carlos Santos
authors.initials: CS
authors.lastname: Ramírez
authors.forename: Esteban Salas
authors.initials: ES
authors.lastname: Heredia
authors.forename: Juan Molina
authors.initials: JM
authors.lastname: García
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000097:blood* / Q000494:pharmacology* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000097:blood* / Q000494:pharmacology* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D000069285:Infliximab; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000069285:Infliximab; D000068879:Adalimumab